• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Jin Li, Shukui Qin, +17 authors Tae Won Benjamin Kim
  • Medicine
  • The Lancet. Oncology
  • 1 June 2015
  • BACKGROUND In the international randomised phase 3 CORRECT trial (NCT01103323), regorafenib significantly improved overall survival versus placebo in patients with treatment-refractory metastaticContinue Reading
  • Atsushi Ohtsu, Jaffer A. Ajani, +17 authors Eric Van Cutsem
  • Medicine
  • Journal of clinical oncology : official journal…
  • 1 November 2013
  • PURPOSE The oral mammalian target of rapamycin inhibitor everolimus demonstrated promising efficacy in a phase II study of pretreated advanced gastric cancer. This international, double-blind, phaseContinue Reading
  • Taroh Satoh, Ruihua Xu, +16 authors Y Bang
  • Medicine
  • Journal of clinical oncology : official journal…
  • 1 July 2014
  • PURPOSE In Asian countries, paclitaxel once per week is used as second-line treatment in advanced gastric cancer, including human epidermal growth factor receptor 2 (HER2) -positive tumors. The roleContinue Reading
  • Jin-Tung Liang, Kuo-Chin Huang, +9 authors King-Jen Chang
  • Medicine
  • International journal of cancer
  • 20 October 2002
  • The influence of MSI on treatment outcome of colorectal cancers remains unclear and deserves further investigation. We recruited 244 patients with stage IV sporadic colorectal cancers for our study,Continue Reading
    BACKGROUND Anecdotal reports have suggested that systemic chemotherapy with agents that better cross the blood-brain barrier may result in long term disease remission in some patients with centralContinue Reading
  • K. H. Yeh, Yanshuang Chen, S H Yeh, Chien Peter Chen, Jui Teng Lin, Ann Lii Cheng
  • Biology, Medicine
  • Anticancer research
  • 1998
  • Intermediate filament cytokeratin-19 (K19) protein is expressed in normal and malignant gastrointestinal epithelial cells, but not in peripheral blood (PB). Small amount of circulating gastric cancerContinue Reading